MedTrace Logo

Molecular Regulation of Muscle Glucose Metabolism

NCT01581736 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2017-11-27

No results posted yet for this study

Summary

This protocol is being conducted to determine the mechanisms responsible for insulin resistance, obesity and type 2 diabetes.

Conditions

Interventions

DRUG

U100 Humulin

Infused at a rate of 80/mU/m2 surface area per minute one time over 2 hours

OTHER

Exercise

Single episode of exercise riding a stationary bike.

Sponsors & Collaborators

  • Arizona State University

    collaborator OTHER

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Lori Roust, MD · Mayo Clinic

  • Lawrence J. Mandarino, PhD · Mayo Clinic

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01581736 on ClinicalTrials.gov